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Abstract
Introduction: The purpose of this study was to explore a data set of patients with fibromyalgia (FM), rheumatoid
arthritis (RA) and systemic lupus erythematosus (SLE) who completed the Revised Fibromyalgia Impact
Questionnaire (FIQR) and its variant, the Symptom Impact Questionnaire (SIQR), for discriminating features that
could be used to differentiate FM from RA and SLE in clinical surveys.
Methods: The frequency and means of comparing FM, RA and SLE patients on all pain sites and SIQR variables
were calculated. Multiple regression analysis was then conducted to identify the significant pain sites and SIQR
predictors of group membership. Thereafter stepwise multiple regression analysis was performed to identify the
order of variables in predicting their maximal statistical contribution to group membership. Partial correlations
assessed their unique contribution, and, last, two-group discriminant analysis provided a classification table.
Results: The data set contained information on the SIQR and also pain locations in 202 FM, 31 RA and 20 SLE
patients. As the SIQR and pain locations did not differ much between the RA and SLE patients, they were grouped
together (RA/SLE) to provide a more robust analysis. The combination of eight SIQR items and seven pain sites
correctly classified 99% of FM and 90% of RA/SLE patients in a two-group discriminant analysis. The largest
reported SIQR differences (FM minus RA/SLE) were seen for the parameters “tenderness to touch,”“ difficulty
cleaning floors” and “discomfort on sitting for 45 minutes.” Combining the SIQR and pain locations in a stepwise
multiple regression analysis revealed that the seven most important predictors of group membership were mid-
lower back pain (29%; 79% vs. 16%), tenderness to touch (11.5%; 6.86 vs. 3.02), neck pain (6.8%; 91% vs. 39%), hand
pain (5%; 64% vs. 77%), arm pain (3%; 69% vs. 18%), outer lower back pain (1.7%; 80% vs. 22%) and sitting for 45
minutes (1.4%; 5.56 vs. 1.49).
Conclusions: A combination of two SIQR questions ("tenderness to touch” and “difficulty sitting for 45 minutes”)
plus pain in the lower back, neck, hands and arms may be useful in the construction of clinical questionnaires
designed for patients with musculoskeletal pain. This combination provided the correct diagnosis in 97% of
patients, with only 7 of 253 patients misclassified.
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Rheumatoid arthritis (RA), systemic lupus erythematosus
(SLE) and fibromyalgia (FM) are usually easily discrimi-
nated on clinical examination, but have several overlap-
ping features that make their differentiation more
problematic in epidemiological surveys. For instance,
pain, fatigue and morning stiffness are commonly
reported in all three disorders. The current study was sti-
mulated by the increasing interest in developing ques-
tionnaires that can accurately predict the occurrence of
FM in both epidemiological and clinical settings [1-5].
During the evaluation of an updated version of the Fibro-
myalgia Impact Questionnaire (FIQR), we compared its
properties in patients with FM with those in patients
with RA, SLE and major depressive disorder (MDD) [6].
Although the primary intent of this analysis was to vali-
date the FIQR as a useful instrument in assessing the
overall impact and severity of FM, it was incidentally
noted that it had some diagnostic utility in differentiating
FM from SLE and RA [6]. A slightly modified version of
the FIQR, the Symptom Impact Questionnaire (SIQR),
was used for the SLE and RA groups. The SIQR is identi-
cal to the FIQR, but does not contain any reference to
FM [6]. For instance, the total SIQR score discriminated
FM from these three disorders, with FM having a total
FIQR score of 56.6, whereas RA had a score of 27.9, SLE
had a score of 29.5 and MDD had a score of 17.3. We
also reported on pain in 24 locations in the FIQR study
to confirm that FM patients who had not been seen
recently still had widespread pain. While this pain loca-
tion questionnaire was not used in FIQR scoring, the
number of pain locations was, as expected, much higher
in FM patients: 16 pain sites for patients with FM com-
pared to 6 sites in patients with RA, 7 sites in patients
with SLE, 4 sites in patients with MDD and 1.6 sites in
healthy controls. The objective of the current study was
to identify individual SIQR symptoms and pain locations
that best discriminated FM patients from RA/SLE
patients in this data set. Doing so provides some pointers
as to which pain sites and common symptoms may best
discriminate FM from RA/SLE in patient questionnaires.
Materials and methods
The data analyzed are taken from the revision of the FIQ
(the FIQR) and its non-FM variant, the SIQR. The Bennett
et al. [6] study compared a sample of healthy controls with
FM, RA, SLE and MDD patients. All data were analyzed
using STATISTICA version 8 software (StatSoft, Inc.
Tulsa, OK, USA). In the present study, we compared the
data from 202 FM patients, 20 SLE patients and 31 RA
patients. The MDD group was not used, because the sam-
ple size of 11 was too small for classification purposes.
The SIQR questionnaire is provided in Table 1. The
SIQR differs from the original FIQ [7] in that it has
modified function questions and new items related to
memory, tenderness, balance and environmental sensi-
tivity. It consists of three domains: Function (nine
items), Overall Impact (two items) and Symptoms (ten
items) that are scored on a scale from 0 to 10, with 10
being the most severe (Table 1). The 24 pain locations
that were used to confirm that FM patients still had
widespread pain were as follows: left shoulder, right
shoulder, left jaw, right jaw, left upper back, right upper
b a c k ,l e f ta r m ,r i g h ta r m ,l e f th a n d ,r i g h th a n d ,l e f t
lower back, right lower back, left hip, right hip, left
thigh, right thigh, left knee, right knee, left foot, right
foot, mid-upper back, mid-lower back and front of chest
and neck (see Table 2). These locations were designed
to reflect a distribution of widespread pain in terms of
10 axial pain locations above and below the waist (neck,
left and right jaw, left and right upper back, left and
right lower back, mid-upper back, mid-lower back and
chest), 8 proximal limb locations (shoulders, arms, hips
and thighs) and 6 distal limb locations (hands, feet and
knees).
Patients
The data from this study were derived from the same
patients who had completed the FIQR and SIQR ques-
tionnaires for the previously published paper [6]. Ethical
approval for reanalysis of these data was not required by
our institutional guidelines. All participants had com-
pleted online informed consent forms, and the study
was conducted in accordance with the Declaration of
Helsinki.
Statistical analyses
First, the frequency and means comparing FM, RA and
SLE participants on all pain sites and SIQR variables are
presented and analyzed. Second, multiple regression ana-
lysis was conducted to identify the significant pain site
and SIQR predictors of group membership (FM and RA/
SLE). A two-step analytic and variable reduction proce-
dure was used. Standard multiple regression analysis
identified the significant and unique predictors of group
membership, thereby reducing the number variables from
35 to 15. Then stepwise multiple regression analysis was
performed, which ordered these 15 variables according to
their maximal statistical contribution in predicting FM
and RA/SLE membership. Partial correlations assessed
their unique contribution, and two-group discriminant
analysis provided a classification table [8].
Results
Pain site frequency
The 10 left- and 10 right-side pain locations (for both
right and left sides: jaws, shoulders, upper outer back,
lower outer back, arms, hands, hips, thighs and feet)
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Page 2 of 10Table 2 Percentage pain site response for RA, SLE and FM with the calculated differences between groups (including
the combined RA/SLE group)
Location Healthy (n = 204) FM (n = 202) RA (n = 31) SLE (n = 20) RA minus SLE RA/SLE (n = 51) FM minus RA/SLE
Shoulders 14% 76% 32% 25% 7% 29% 48%
Jaws 4% 36% 3% 10% -7% 7% 30%
Arms 6% 69% 23% 10% 13% 16% 53%
Hands 5% 64% 81% 73% 9% 77% -13%
Hips 11% 79% 29% 28% 2% 28% 51%
Thighs 4% 55% 0% 0% 0% 0% 55%
Knees 10% 64% 39% 53% -14% 46% 18%
Feet 12% 50% 46% 63% -17% 54% -4%
Lateral upper back 6% 82% 15% 23% -8% 19% 64%
Lateral lower back 8% 80% 23% 20% 3% 22% 59%
Mid upper back 4% 77% 13% 15% -2% 14% 63%
Mid lower back 16% 79% 10% 25% -15% 18% 62%
Front of chest 4% 54% 10% 15% -5% 13% 42%
Neck 16% 91% 29% 55% -26% 42% 49%
Peripheral 7% 55% 28% 29% -1% 28% 26%
Axial 9% 77% 17% 25% -9% 21% 56%
Note: Minus scores in the RA minus SLE column indicate that the SLE group had higher scores on that item. Minus scores in the FM minus RA/SLE column
indicate that the RA/SLE group had higher scores on that item. FM, fibromyalgia; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.
Table 1 The Symptom Impact Questionnaire (SIQR)
Domain 1: For each question, place an “X” in the box that best indicates how much difficulty you have experienced in doing the
following activities during the past 7 days. If you did not perform a particular activity in the last 7 days, rate the difficulty for the last
time you performed the activity. If you can’t perform an activity, check the last box.
Brush or comb your hair No difficulty □□□□□□□□□□□ Very difficult
Walk continuously for 20 minutes No difficulty □□□□□□□□□□□ Very difficult
Prepare a homemade meal No difficulty □□□□□□□□□□□ Very difficult
Vacuum, scrub or sweep floors No difficulty □□□□□□□□□□□ Very difficult
Lift and carry a bag full of groceries No difficulty □□□□□□□□□□□ Very difficult
Climb one flight of stairs No difficulty □□□□□□□□□□□ Very difficult
Change bed sheets No difficulty □□□□□□□□□□□ Very difficult
Sit in a chair for 45 minutes No difficulty □□□□□□□□□□□ Very difficult
Go shopping for groceries No difficulty □□□□□□□□□□□ Very difficult
Domain 2: For each of the following 2 questions, check the one box that best describes the overall impact of any medical problems over
the last 7 days.
My medical problems prevented me from accomplishing goals. Never □□□□□□□□□□□ Always
I was completely overwhelmed by my medical problems Never □□□□□□□□□□□ Always
Domain 3: For each of the following 10 questions, check the one box that best indicates the intensity of the following common
symptoms over the last 7 days.
Please rate your level of pain No pain □□□□□□□□□□□ Unbearable pain
Please rate your level of energy Lots of energy □□□□□□□□□□□ No energy
Please rate your level of stiffness No stiffness □□□□□□□□□□□ Severe stiffness
Please rate the quality of your sleep Awoke rested □□□□□□□□□□□ Awoke very tired
Please rate your level of depression No depression □□□□□□□□□□□ Very depressed
Please rate your level of memory problems Good memory □□□□□□□□□□□ Very poor memory
Please rate your level of anxiety Not anxious □□□□□□□□□□□ Very anxious
Please rate your level of tenderness to touch No tenderness □□□□□□□□□□□ Very tender
Please rate your level of balance problems No imbalance □□□□□□□□□□□ Severe imbalance
Please rate your level of sensitivity to loud noises, bright lights, odors and cold No sensitivity □□□□□□□□□□□ Extreme sensitivity
Scoring: (1) Sum the scores for each of the three domains (Function, Overall and Symptoms). (2) Divide domain 1 score by 3, divide domain 2 score by 1 (that is,
unchanged) and divide domain score 3 by 2. (3) Add the three resulting domain scores to obtain the total SIQR score (range, 0 to 100).
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Page 3 of 10were highly correlated (range, rs = 0.66 to 0.85; mean, r =
0.77). To avoid multicollinearity and reduce the number
of variables, the left and right sides were averaged to form
10 variables, which, together with the 4 axial sites (mid-
upper back, mid-lower back, neck and front of chest),
formed the 14 pain sites used as predictors. Table 2 shows
the percentages of healthy controls and FM, RA, SLE and
RA patients, as well as RA combined with SLE patients
(RA/SLE), who reported pain at these 14 pain sites. The
data for healthy patients are also included to provide a
baseline for comparison. The first four of columns Table 2
show the pain site percentages in healthy controls and
FM, RA and SLE patients. To discern whether there was
much difference between RA and SLE patients, the fifth
column shows the calculated difference between these two
groups. The sixth column shows the combined RA and
SLE figures (RA/SLE), and the last column shows the FM
minus RA/SLE difference, a measure of discriminatory
sites. Interestingly, there was not a very large discordance
between pain sites in RA and SLE patients, except for
neck pain, which was endorsed by 55% of SLE patients
versus 29% of RA patients (P < 0.0001). As might be
expected, hand pain was more common in RA patients,
but foot and knee pain were unexpectedly more common
in SLE patients. FM patients generally reported many
more pain locations than RA/SLE patients, except, as
might be expected, for the hands and feet. FM patients fre-
quently reported pain in the extremities and thus a report
of hand and/or foot pain does not necessarily discriminate
FM from RA/SLE patients. The bottom two rows show
the average percentage of patients with pain in peripheral
and axial locations. FM patients more often reported axial
pain, with an average frequency of 77% in axial locations
compared to an average frequency of 21% among RA/SLE
patients (P < 0.0004). Interestingly, peripheral pain loca-
tions were more prevalent in FM patients than in RA/SLE
patients (55% vs. 28%, P < 0.0002). A notable pain location
was the thigh; this was never reported in RA/SLE patients,
whereas 55% of FM patients had pain in this region. Jaw
pain was reported in 36% of FM patients but in only 7% of
RA/SLE patients (P < 0.0001). It is relevant to note that
the FM minus RA/SLE differences are really “zero order
relations” and do not necessarily identify unique differ-
ences after controlling for other predictors (see section,
‘Forward stepwise regression analysis of pain sites and
SIQR predictors of group membership’).
The fairly close concordance of pain sites in RA and
SLE patients provides some justification for merging
them into a single group (RA/SLE) to increase statistical
power and permit regression and discriminant analyses.
SIQR item frequency
Table 3 shows the SIQR scores of healthy controls and
FM, SLE and RA patients, as well as RA patients combined
with SLE patients (RA/SLE). The computed total SIQR
score (bottom row) and the function, overall and symptom
averages were also computed. As in the case of the pain
site frequency table, the last column (FM minus RA/SLE)
provides some indication of the possible items that are
most discriminatory between FM and RA/SLE. The high-
est differences (≥3.5) were seen for difficulty cleaning
floors, discomfort on sitting for 45 minutes and tenderness
to touch, all of which were more severe in FM patients.
The averaged total SIQR score in FM patients was 56.6
versus 28.6 in RA/SLE patients (P < 0.0001). The RA
minus SLE column shows very little difference between
RA and SLE patients (all < 0.8), with the exceptions of
environmental sensitivity (-2.9, 1.6 vs. 4.5; P <0 . 0 0 1 ) ,
which was more of a problem for the SLE group, and
climbing one flight of stairs (1.3, 3.6 vs. 2.3; P =0 . 0 6 ) ,
which was more difficult for the RA group. Overall, these
results, along with the pain site frequency findings, provide
reasonable justification for merging the RA and SLE
groups in the following analyses.
Pain site and SIQR predictors of FM and RA/SLE group
membership and classification analyses
A preliminary standard multiple regression analysis was
performed with the 14 pain site variables and 21 SIQR
variables to identify which variables were uniquely and
statistically associated with FM vs. RA/SLE group mem-
bership. This analysis identified 11 significant variables:
neck, P < 0.0009; arms, P < 0.002; hands, P < 0.003;
lower back, P <0 . 0 4 6 ;t h i g h ,P <0 . 0 3 3 ;f e e t ,P <0 . 0 0 7 ;
tenderness to touch, P < 0.0001; cleaning floors, P <
0.002; sitting for 45 minutes, P <0 . 0 0 3 ;d e p r e s s i o n ,P <
0.01; and anxiety, P < 0.034. Four other variables, mid-
lower back pain (P < 0.08), feeling overwhelmed (P <
0.065), poor memory (P < 0.09) and environmental sen-
sitivity (P < 0.09), were marginally significant and were
retained in the final regression analysis model so as not
to preclude their possible contribution in a final analysis.
The seven pain site and eight SIQR variables were then
entered into a forward stepwise regression analysis
(Table 4) to identify which variables best discriminated
the FM from the RA/SLE group. Table 5 shows their
unique contribution (partial correlations) when the
other 14 variables were controlled for. Last, discriminant
function analysis was used to classify FM and RA/SLE
individuals according to this final variable list (Table 6).
Forward stepwise regression analysis of pain sites and
SIQR predictors of group membership
A forward stepwise regression model (Table 4) with 15
predictors combined to produce a multiple r = 0.809
(see Table 4, bottom row, column 2), accounting for
65% of variance associated with group membership (see
Table 4, column 3). Additional hierarchical regression
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Page 4 of 10Table 3 Individual SIQR questions for RA, SLE and FM with the calculated differences between RA and SLE and
between FM and the combined RA/SLE groups
SIQR question Healthy
(n = 204)
FM
(n = 202)
RA
(n = 31)
SLE
(n = 20)
RA minus SLE RA/SLE
(n = 51)
FM minus RA/SLE
Brush or comb hair 0.1 2.4 0.9 0.8 0.1 0.8 1.6
Walk continuously for 20 minutes 0.6 5.7 3.4 2.2 1.2 2.9 2.8
Prepare a homemade meal 0.2 4.3 1.2 1.4 -0.2 1.3 3.0
Vacuum, scrub or sweep floors 0.6 6.5 2.8 2.5 0.3 2.7 3.8
Lift and carry a bag full of groceries 0.4 5.6 2.6 3.3 -0.7 2.9 2.7
Climb one flight of stairs 0.5 5.6 3.6 2.3 1.3 3.1 2.5
Change bed sheets 0.4 5.5 2.4 2.2 0.2 2.3 3.2
Sit in a chair for 45 minutes 0.7 5.6 1.5 1.6 -0.1 1.5 4.1
Go shopping for groceries 0.4 5.6 2.5 2.4 0.1 2.4 3.2
Function (average) 0.4 5.2 2.3 2.1 0.2 2.2 3.0
Achieve goals 0.7 5.7 2.7 3.1 -0.4 2.8 2.9
Feel overwhelmed 0.7 5.2 2.5 3.3 -0.8 2.8 2.4
Overall (average) 0.7 5.5 2.6 3.2 -0.6 2.8 2.7
Pain 1.5 6.0 3.9 4.1 -0.2 3.9 2.1
Energy 2.6 6.8 5.1 5.1 0.0 5.1 1.7
Stiffness 2.1 6.7 4.5 4.1 0.4 4.4 2.3
Sleep 3.8 7.6 5.4 5.5 -0.1 5.5 2.1
Depression 1.7 4.6 1.8 1.8 0.0 1.8 2.8
Memory 1.7 5.9 2.7 3.4 -0.7 3.0 2.9
Anxiety 1.8 4.5 1.9 2.6 -0.7 2.2 2.3
Tenderness 1.0 6.9 3.4 2.5 0.9 3.0 3.9
Balance 0.7 4.8 2.0 1.8 0.2 1.9 2.9
Sensitivity 1.5 6.2 1.6 4.5 -2.9 2.8 3.4
Symptoms (average) 1.8 6.0 3.2 3.5 -0.3 3.3 2.7
Total SIQR score 12.4 56.6 27.9 29.6 -1.7 28.6 28.0
Note: Minus scores in the RA minus SLE column indicate that SLE group had higher scores on that item. Higher scores indicate more impairment or higher level
of symptoms. FM, fibromyalgia; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.
Table 4 Stepwise multiple regression showing 15 predictors ranked in order of magnitude in predicting group
membership (FM or RA/SLE)
Predictors Step and number of variables included Multiple R Multiple R
2 R
2 change P value for predictor variable
Mid-lower back 1 0.540 0.291 0.291 0.00000
Tenderness to touch 2 0.637 0.406 0.115 0.00000
Neck 3 0.689 0.474 0.068 0.00000
Arms 4 0.712 0.507 0.033 0.00007
Hands 5 0.747 0.558 0.051 0.00000
Lateral lower back 6 0.758 0.575 0.017 0.00168
Sitting for 45 minutes 7 0.768 0.589 0.014 0.00367
Feeling overwhelmed 8 0.775 0.601 0.012 0.00750
Depression 9 0.784 0.615 0.014 0.00365
Sensitivity 10 0.791 0.626 0.011 0.00855
Thighs 11 0.797 0.635 0.009 0.01471
Feet 12 0.804 0.647 0.012 0.00529
Cleaning floors 13 0.806 0.649 0.003 0.16326
Anxiety 14 0.807 0.652 0.002 0.19893
Memory 15 0.809 0.654 0.002 0.21899
Note: This forward stepwise regression analysis used 15 predictors which combined to produce a multiple R = 0.809 (last row, column 2). This accounted for 65%
of variance associated with group membership (column 3). FM, fibromyalgia; RA/SLE, combined rheumatoid arthritis and systemic lupus erythematosus group.
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Page 5 of 10analyses (not shown) indicated that this 65% variance
could be further decomposed into 30% of variance
shared between SIQR and pain sites, 24% unique to
pain sites and 11% unique to SIQR variables. With
regard to the 15 predictors, the first 7 predictors parti-
cularly (mid-lower back pain, neck pain, arm pain, hand
pain, outer lower back pain, tenderness to touch and sit-
ting for 45 minutes) accounted for almost 60% of this
variance. These seven most important predictors of
group membership in order of magnitude (variance
accounted for and FM vs. RA/SLE differences indicated)
were mid-lower back pain (29%; 79% vs. 18%), tender-
ness to touch (11.5%; 6.86 vs. 3.02), neck pain (6.8%;
91% vs. 42%), hand pain (5%; 64% vs. 77%), arm pain
(3%; 69% vs. 16%), outer lower back pain (1.7%; 80% vs.
22%) and sitting for 45 minutes (1.4%; 5.56 vs. 1.49).
Mid- and lower-back pain, though they showed strong
zero order correlation and quite different percentages in
Table 2, have smaller partial correlations in Table 5
because of their shared variance as indicated by their
quite strong correlation with each other (r = 0.56). In
fact, while mid-lower back pain was the first variable to
be entered into the stepwise regression analysis, being
responsible for 29.1% of variance (Table 3, column 4), the
corresponding partial coefficient, indicating unique contri-
bution, was only -0.129 (Table 5, column 3). On the other
hand, tenderness to touch and neck pain contributed both
substantial and unique variance. It is of note that hand
and foot pain, which are not much different in Table 2
and have low zero order correlations in Table 5 (-0.162
and -0.021, respectively), had stronger unique and statisti-
cally significant partial relations (0.237 and 0.176, respec-
tively), thus indicating stronger associations with RA/SLE.
It is also relevant to note that the magnitude of the FM
minus RA/SLE pain site differences in Table 2 and correla-
tions in Table 5 (which are zero order relations) are not
completely reflected by the results of the multivariate
regression analysis, as exemplified by the partial correla-
tions in Table 5. Of the 14 pains sites listed in Table 3, the
5 most important pain sites in Table 5 that discriminate
FM from RA/SLE are the mid- and outer lower back,
neck, arms and hands. Similarly, of the 23 SIQR items, the
important variables are “tenderness to touch” and “sitting
in a chair for 45 minutes.” While the SIQR “tenderness”
variable was a strong predictor of group assignment, the
SIQR “pain” variable did not distinguish FM from RA/
SLE. Overall, these variables suggest that the relationship
between predictors and group membership can be best
d e s c r i b e db yan u m b e ro fs p e c i fic pain locations plus a
high level of tenderness to touch.
Other unique predictors and considerations: pain,
tenderness, and pain sites in FM and RA/SLE
Given that SIQR tenderness was an important discrimi-
nator of RA/SLE groups and SIQR pain was not, further
analyses were conducted to provide some insight as to
how pain, tenderness and pain sites function in relation
to each other and also to FM and RA/SLE.
Mean differences in SIQR tenderness and SIQR pain in FM
and RA/SLE
A repeated measures 2 × 2 analysis of variance (FM, RA/
SLE × tenderness, pain) was performed on the means for
FM and RA/SLE. A main effect [F(1, 251) = 84.87; P <
0.0001)] showed that FM patients, compared with RA/
SLE patients, reported significantly more tenderness (6.86
vs. 3.02; P < 0.001) and pain (6.01 vs. 3.94; P < 0.008).
An interaction [F(1, 251) = 20.17, P < 0.0001)] comparing
the two patient groups shows that this approximates a
four-point difference for tenderness relative to a two-
point difference for pain. These differences may in part
account for why tenderness but not pain was a stronger
predictor in classifying patients in the discriminant analy-
sis. Additionally, the FM group reported more tenderness
than pain (6.86 vs. 6.01; P < 0.001), while RA/SLE
patients reported slightly more pain than tenderness (3.94
vs. 3.02; P =0 . 0 1 9 ) .T h u s“tenderness” was rated higher
by FM patients, while pain was rated higher by RA/SLE
Table 5 Forward stepwise multiple regression analysis
showing zero order (Pearson’s r) and partial correlations
Predictors Pearson’s r Partial rP value (partial r)
Mid-lower back -0.540 -0.129 0.0458
Tenderness to touch -0.518 -0.242 0.0002
Neck -0.518 -0.275 0.0000
Arms -0.447 -0.261 0.0000
Hands 0.162 0.237 0.0002
Lateral lower back -0.524 -0.191 0.0030
Sitting for 45 minutes -0.475 -0.177 0.0060
Feeling overwhelmed -0.314 0.274 0.0000
Depression -0.378 -0.190 0.0031
Sensitivity -0.422 -0.144 0.0258
Thighs -0.474 -0.166 0.0101
Feet 0.021 0.176 0.0064
Cleaning floors -0.452 -0.085 0.1914
Anxiety -0.292 0.099 0.1277
Memory -0.428 -0.080 0.2190
Note: Minus correlations indicate that FM patients have higher scores on
predictor variable. All Pearson’s correlations are significant (N =2 5 3 ;P <0 . 0 0 1 )
except hands (P <0 . 0 1 )a n df e e t( P <0 . 7 4 ) .
Table 6 Correct classification as predicted by
discriminant analysis using seven pain sites and eight
SIQR variables
Group FM RA/SLE Percent correct
FM (n = 202) 200 2 99.01%
RA/SLE (n = 51) 5 46 90.20%
Note: The combined correct classification for FM and RA/SLE = 97.23%. FM,
fibromyalgia; RA/SLE, combined rheumatoid arthritis and systemic lupus
erythematosus group.
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2 test indicated that 58% vs.
25% of FM and RA/SLE patients, respectively, indicated a
greater tenderness than pain score (P < 0.001).
SIQR pain and SIQR tenderness prediction of total pain site
A second analysis using standard multiple regression was
conducted to determine how tenderness and pain,
uniquely and together, predicted total pain site scores in
the FM and RA/SLE groups separately. In FM patients,
pain (b = 0.277, P = 0.0002) and tenderness (b = 0.181, P
= 0.013) were both independent predictors of total pain
site scores (R = 0.389, P = 0.001). In the RA/SLE group,
only pain (b = 0.472, P = 0.003) but not tenderness (b =
0.042, P = 0.78) predicted total pain sites (R = 0.497, P =
0.001). This demonstrates that while SIQR pain predicts
pain sites in both groups, tenderness to touch predicts
pain sites only in the FM group.
Along with the regression analyses, the latter analyses
point to several conclusions. First, FM patients reported
higher tenderness than pain scores, whereas the reverse
was true of RA/SLE patients, who reported higher pain
than tenderness scores. Second, tenderness to touch
seems to be an important “between group” variable in
discriminating FM from RA/SLE patients, whereas pain
is not. Third, both pain and tenderness are independent
predictors of pain sites in FM patients, whereas only
pain is a predictor of pain sites in RA/SLE patients. Col-
lectively, these analyses show that tenderness to touch
plays a unique role in differentiating FM from RA/SLE
and is a unique predictor of pain sites in FM patients
but not in RA/SLE patients. With regard to RA/SLE
patients, pain was rated higher than tenderness to touch
and was correlated with pain sites, whereas tenderness
was not. These findings indicate that variables predicting
between-group identificati o nd os oi nad i f f e r e n tw a y
than they do in predicting within-group severity differ-
ences. Notably, tenderness to touch plays a unique role
in both differentiating FM from RA/SLE patients and in
predicting FM severity (in addition to pain) among FM
patients.
Discussion
This analysis of FIQR/SIQR items and 24 pain locations
provides some potentially useful pointers to questions
that could be used in the construction of epidemiologi-
cal questionnaires in surveys of musculoskeletal pain.
The questions in the SIQR reflect the domains (pain,
tenderness, fatigue, multidimensional function and
sleep) that the Outcome Measures in Rheumatology
Clinical Trials (OMERACT) [9] has recommended as
core dimensions to be assessed in all FM clinical trials.
The SIQR includes domains that are also deemed to be
important by OMERACT (that is, fatigue, dyscognition,
stiffness, depression and anxiety). The SIQR items relat-
ing to balance and environmental sensitivity have not
been evaluated in the OMERACT process, but are some
of the commonest complaints of FM patients [10].
While the classification criteria for RA, SLE and FM
all require a physical examination, epidemiological sur-
veys seldom provide for patient examination, thus the
development of discriminatory questionnaires is proble-
matical. The one physical examination criterion for FM,
as per the 1990 American College of Rheumatology
(ACR) classification criteria, is the finding of ≥11 of 18
designated tender points [11]. Reporting on tenderness
of joints is part of the ACR and Disease Activity Score
(DAS) system in the evaluation of RA severity [12,13].
One might logically surmise that the symptom of ten-
derness to touch that is “whole body,” as in FM, would
be more severe than focal joint tenderness in RA, which
is what we found in this analysis. Although the finding
of inflammatory arthritis in two or more joints is one of
the eleven criteria used in SLE classification [14], ten-
derness per se is not part of these criteria. Thus it was
of interest to note that in this analysis, tenderness to
touch in SLE patients was similarly rated in RA and SLE
patients (2.9 vs. 3.4).
Overall the combination of seven pain sites and eight
SIQR items together produced a multiple R of 0.81 (65%
variance), accounting for substantial variance in group
membership, with a correct classification rate of 97%.
From a conceptual perspective, it is interesting to note
that the largest component of this variance (30%) was
shared by pain sites and SIQR items, indicating that
Comparison of Tenderness and Pain in subjects
ith FM RA/SLE and Health controls with FM, RA/SLE and Healthy controls 
10
Tenderness P <0 0001
P <0.0001 
8 Pain
P <0.0001 
P <0.001 
4
6
P <0.02 
2
4
0
2
FM RA/SLE HLTH
Figure 1 The main effect shows that both tenderness and pain
are significantly greater in fibromyalgia than in rheumatoid
arthritis/systemic lupus erythematosus. However, the interaction
shows that (a) this difference is greater in fibromyalgia (FM) than in
rheumatoid arthritis/systemic lupus erythematosus (RA/SLE) and (b)
tenderness is more severe than pain in FM, whereas pain
predominates over tenderness in RA/SLE. The healthy control values
are provided for background comparison. HLTH, healthy controls.
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nected in differentiating FM from RA/SLE. The addi-
tional unique contribution of pain sites (24%) and SIQR
items (11%), particularly tenderness to touch, suggest
that epidemiological surveys should consider both of
these items to maximize their effectiveness. But neither
pain sites nor SIQR variables alone seem sufficient to
differentiate patient groups. The role of SIQR pain was
different and also significant when examining within-
group correlations rather than correlations across
groups (pooled across groups) as described above. Both
SIQR pain and SIQR tenderness to touch significantly
predicted pain site scores in the FM group, while only
SIQR pain predicted total pain site scores in the RA/
SLE group. Furthermore, the means for SIQR tenderness
to touch and SIQR pain were different, thus showing
discriminant validity between FM and RA/SLE.
A notable finding in this study was that the SIQR
question on tenderness to touch, along with neck pain,
arm pain and hand pain, were important symptoms to
consider when developing questionnaires to distinguish
FM from RA or SLE. In all analyses, tenderness contrib-
uted equally with other specific pain sites to the classifi-
cation of FM and RA/SLE patients. The SIQR pain
variable did not help to distinguish FM from RA or SLE
patients, possibly because the pain site captures pain rat-
ings, thus making the SIQR “pain” variable redundant.
This notion is supported by the observation that tender-
ness was correlated with pain (0.55), but was more
strongly associated with group diagnosis than pain (0.52
vs. 0.35).
Nevertheless, while pain and tenderness uniquely pre-
dicted pain sites, they did not account for much var-
iance in pain site. A more refined measure of pain
locations, such as a pain VAS, one that specified the
nature or quality of the pain in greater detail or one
which included axial, distal and proximal subscale
scores, might provide more useful information than a
simple count of presence or absence of pain.
We are not aware of other survey questionnaires that
ask about “tenderness to touch.” However, the recent
preliminary diagnostic FM criteria paper did find that a
widespread pain index and muscle tenderness were the
most important variables in the classification of cases and
noncases of FM, although tenderness was not used in the
final formulation of the criteria [4]. It seems possible that
the “tenderness to touch” variable may be a useful surro-
gate for a tender point evaluation in musculoskeletal pain
surveys without a physical examination. It is also worthy
of comment that “tenderness to touch” was associated
with a diagnosis of FM even when psychological variables
such as depression, anxiety and “feeling overwhelmed”
were controlled for in multivariate regression analyses,
thus challenging the still common notion that tenderness
in FM can be explained in terms of a psychiatric condi-
tion or a psychosomatic reaction. Looking backward to
the 1990 ACR study, the finding of “tenderness to touch”
is redolent of the “skin-fold tenderness” test, which pro-
vided odds ratios of 8.8 and 6.5, respectively, for the diag-
nosis of primary FM and secondary FM over controls
[11].
Although FM patients had higher pain scores than
RA/SLE patients (6.0 vs. 3.9), pain was not a useful
between-group discriminator. We surmised that this was
due to pain locations being a better discriminator. The
SIQR only asks about pain in the general sense, and
maybe more specific questions would be useful in epide-
miological surveys. For instance, Perrot et al. [3]
reported on the development of a rapid screening tool
for FM and found that positivity for at least five of six
questions ("I have pain all over my body,”“ My pain is
accompanied by continuous and very unpleasant general
fatigue,”“ My pain feels like burns, electric shocks or
cramps,” My pain is accompanied by other unusual sen-
sations throughout my body, such as pins and needles,
tingling or numbness,”“ My pain is accompanied by
other health problems such as digestive problems, urin-
ary problems, headaches or restless legs,” and “My pain
has a significant impact on my life, particularly on my
sleep and my ability to concentrate, making me feel
slower generally”) had a sensitivity of 90.5% and a speci-
ficity of 85.7% in differentiating FM from a composite
group comprising non-FM with RA, ankylosing spondy-
litis and osteoarthritis.
There are several limitations of the present study. The
number of RA/SLE patients was small compared to the
FM population (51 vs. 202). The pain locations were
designed to reflect a composite of widespread pain and
peripheral pain. In this respect, it may have been useful
to include the wrists and ankles, joints that are com-
monly involved in RA. The RA and SLE patients were
specifically screened for not having concomitant FM,
and thus this study does not provide any useful informa-
tion on that common combination, which is now known
to skew the results of questionnaires such as the DAS
[15]. The patients in this study were not screened for
hand osteoarthritis, a condition that is found in about
80% of older adult patients [16]; however, hand pain
was the only pain location that was more prevalent in
RA/SLE than in FM.
While researching background information for this
paper, it became apparent that very little information
has been published regarding musculoskeletal pain in
SLE patients. A typical description is, “Joint involvement
in SLE is similar to that of rheumatoid arthritis, primar-
ily affecting the small joint of the hands, wrists and
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usually out of proportion to the degree of synovitis
present on physical examination” [17]. An inconsistency
of symptoms and objective findings is always suggestive
of central sensitization, as exemplified by FM. While FM
is a common accompaniment of SLE [18], the SLE
patients in this study were specifically screened not to
have concomitant FM. The success of this screening
was validated by the relatively low FIQR/SIQR scores
compared to FM (29.6 in SLE vs. 56.6 in FM). The only
SIQR question that significantly differentiated RA from
SLE was sensitivity to “loud noises, bright lights, odors
and cold.” This may be a reflection of sensitivity to sun-
light in SLE patients, but this cannot be inferred from
this data set. The only pain location that significantly dif-
ferentiated RA from SLE was neck pain, with 55% preva-
lence in SLE patients vs. 29% in RA patients. Other
notable nonsignificant differences were a higher preva-
lence of foot pain (63% vs. 46%) and knee pain (53% vs.
39%) in SLE compared to RA. These differences may be
due to the relatively small number of RA and SLE patients,
but if confirmed in a larger data set, these differences
could point to differences in the musculoskeletal symp-
toms of SLE and RA that have hitherto been opaque.
Conclusions
This study analyzed data derived from patients with FM,
SLE or RA who had completed the FIQR and/or SIQR
and identified sites of pain in 24 locations. A combina-
tion of two SIQR questions ("tenderness to touch” and
“difficulty sitting for 45 minutes”) plus pain in four loca-
tions (lower back, neck, hands and arms) identified the
correct diagnosis in 97% of patients. Overall, this report
provides some pointers for distinguishing FM patients
from patients with RA or SLE in clinical questionnaires
and raises some potentially novel issues regarding mus-
culoskeletal symptoms in SLE patients.
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